Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai RAAS Blood Products is a leading Chinese biopharmaceutical company specializing in the research, development, and large-scale production of plasma-derived therapies. The company's extensive product portfolio includes human albumin, intravenous immunoglobulin (IVIG), and various coagulation factors such as Factor VIII and prothrombin complex concentrates. Operating a vast network of plasma collection centers across China, Shanghai RAAS serves as a critical supplier for the treatment of hemophilia, immune disorders, and critical care conditions. The company is recognized for its high standards in viral safety and manufacturing quality within the global blood products industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RAAS.